Business Standard

ICICI Venture to sell Vetnex stake to Pfizer for Rs 200 cr

BS Reporter  |  Mumbai 

today announced signing of a definitive share purchase agreement to sell all common shares of RFCL’s Vetnex Animal Health to of world’s largest drug maker Pfizer. The acquisition is expected to close by August 2009, subject to necessary regulatory approvals.

Vetnex Animal Health is a part of RFCL, a significant stake in which was acquired by ICICI Venture from Ranbaxy Laboratories for Rs 125 crore in 2005.

Though ICICI Venture did not disclose much, sources said the deal was worth over Rs 200 crore and that Vetnex had an annual turnover of Rs 100-120 crore. French animal healthcare majors Virbac and Sanofi-Aventis were also in the race, they said. When contacted, RFCL executives declined to comment.

Vetnex is a market leader in poultry, livestock and pet healthcare and is one of the top three players in the Indian animal healthcare market. The company is valued at about Rs 1,400 crore.

RFCL, which operates in chemicals, diagnostics and animal healthcare sectors, had de-merged its animal health division into Vetnex earlier this year.

RECOMMENDED FOR YOU

ICICI Venture to sell Vetnex stake to Pfizer for Rs 200 cr

ICICI Venture today announced signing of a definitive share purchase agreement to sell all common shares of RFCL’s Vetnex Animal Health to Pfizer Animal Health of world’s largest drug maker Pfizer. The acquisition is expected to close by August 2009, subject to necessary regulatory approvals.

today announced signing of a definitive share purchase agreement to sell all common shares of RFCL’s Vetnex Animal Health to of world’s largest drug maker Pfizer. The acquisition is expected to close by August 2009, subject to necessary regulatory approvals.

Vetnex Animal Health is a part of RFCL, a significant stake in which was acquired by ICICI Venture from Ranbaxy Laboratories for Rs 125 crore in 2005.

Though ICICI Venture did not disclose much, sources said the deal was worth over Rs 200 crore and that Vetnex had an annual turnover of Rs 100-120 crore. French animal healthcare majors Virbac and Sanofi-Aventis were also in the race, they said. When contacted, RFCL executives declined to comment.

Vetnex is a market leader in poultry, livestock and pet healthcare and is one of the top three players in the Indian animal healthcare market. The company is valued at about Rs 1,400 crore.

RFCL, which operates in chemicals, diagnostics and animal healthcare sectors, had de-merged its animal health division into Vetnex earlier this year.

image

LIVE MARKET

BSE 25201.90

-562.88 (-2.18 %)

NSE 7655.05

-167.95 (-2.15%)

Widgets Magazine

STOCK WATCH

Company Price() Chg(%)
Ent.Network 655.60 7.67
Goldline Intl. 194.00 4.81
Jyothy Lab. 320.80 4.73
PMC Fincorp 1.63 4.49
Sun TV Network 387.30 4.00
> More on BSE Gainers
Company Price() Chg(%)
Ent.Network 663.05 8.11
Amtek Auto 32.80 4.13
Sun TV Network 387.65 4.04
Jyothy Lab. 319.90 3.98
La Opala RG 589.70 3.91
> More on NSE Gainers
Company Price() Chg(%)
NCC 58.15 -12.23
Financial Tech. 99.95 -11.55
Welspun Corp 100.55 -8.76
Lycos Internet 23.50 -7.84
H D I L 57.00 -7.77
> More on BSE Gainers
Company Price() Chg(%)
NCC 58.10 -12.04
Financial Tech. 100.10 -11.14
Welspun Corp 100.20 -9.36
Himatsing. Seide 178.65 -7.86
H D I L 57.00 -7.62
> More on NSE Gainers
Widgets Magazine
Widgets Magazine
Widgets Magazine

Derivatives

Index
Instrument Type
Expiry Date
Option Type
Strike Price